pharma · Persistent Corneal Epithelial Defect (PCED) · Recent onset Type 1 Diabetes
Doppel Farmaceutici
Dompe' Farmaceutici S.p.A.
Doppel Farmaceutici clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Via Martiri delle Foibe 1, Cortemaggiore (PC), Emilia-Romagna 29016, IT, napoli HQ
1994 Founded
393 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Via Martiri delle Foibe 1, Cortemaggiore (PC), Emilia-Romagna 29016, IT, napoli
- Founded
- 1994
- Employees
- 393
- Programs
- 11
- Drugs
- 14
- Patents
- 0
Doppel Farmaceutici projects
2 ClinicalTrials.gov programs sponsored by Doppel Farmaceutici.
Doppel Farmaceutici has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Doppel Farmaceutici have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.